Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report. 2013

O P Arewa, and S Nahirniak, and G Clarke
Department of Laboratory Medicine & Blood Bank, Arar Central Hospital, Arar, Saudi Arabia.

Posttransfusion purpura (PTP) is an uncommon, but potentially fatal, transfusion reaction characterized by profound thrombocytopenia and bleeding. PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. Although there is evidence of a wide serological spectrum of culprit antibodies implicated, Anti-human-platelet-antigen- (HPA-) 1a is the most common antibody in cases reported. We report a case of posttransfusion purpura in an African American. The patient was negative for HPA-1a antibodies, but anti-HPA-1b was identified with a platelet phenotype of HPA-1a/HPA-1a. Although less common, HPA-1b antibody may be an important consideration in posttransfusion purpura diagnosed in patients of African descent.

UI MeSH Term Description Entries

Related Publications

O P Arewa, and S Nahirniak, and G Clarke
January 1985, Transfusion,
O P Arewa, and S Nahirniak, and G Clarke
November 2015, Transfusion,
O P Arewa, and S Nahirniak, and G Clarke
January 2001, Lijecnicki vjesnik,
O P Arewa, and S Nahirniak, and G Clarke
July 1994, British journal of haematology,
O P Arewa, and S Nahirniak, and G Clarke
January 1998, Vox sanguinis,
O P Arewa, and S Nahirniak, and G Clarke
October 1991, Transfusion,
O P Arewa, and S Nahirniak, and G Clarke
May 2001, Transfusion,
O P Arewa, and S Nahirniak, and G Clarke
January 1989, Vox sanguinis,
Copied contents to your clipboard!